Indications and uses
For the support & balancing of the Anatomic & Central nervous systems
For the support & balancing of the Anatomic & Central nervous systems
Normal storage use. Do not use if tamper-evident seal is broken or removed.
Choline Chloride 6X 200K, Adrenalin 6X 200K, GABA 6X 200K, Histamine 6X 200K, Hydrastis 3X, Norepinephrine 6X 200K, Taraxacum 3X 30K, Tyramine 6X 200K
| Choline Chloride | Mental clarity |
| Adrenalin | Adrenal support |
| GABA | Mental clarity |
| Histamine | Ig support |
| Hydrastis | Drainage |
| Norepinephrine | Adrenal support |
| Taraxacum | Drainage |
| Tyramine | Neurological support |
For the support & balancing of the Anatomic & Central nervous systems
Stop use and ask a health care practitioner if symptoms persist for more than five days or worsen. If pregnant or breastfeeding, ask a health care practitioner before use.
1-5 spray(s); 1-3 time(s) per day or as recommended by your health care practitioner.
Keep this and all medicines out of reach of children.
Alcohol and Water
Normal storage use.
Do not use if tamper-evident seal is broken or removed.
info@viatrexx.com
ITEM: VPC0025
NDC 63776-033-15
Homeopathic remedy
ANS/CNS
• For the support & balancing of the Anatomic & Central nervous systems
Oral spray
50ml 1.7 oz
Viatrexx™ Bio Incorporated
Manufactured by Viatrexx
www.viatrexx.com
Newark, DE 19713

ANS/CNS
50 mL
1.7 oz
Viatrexx™ Bio Incorporated
ITEM: VPC0025
NDC: 63776-033-15
INDICATIONS:
For the support & balancing of the Anatomic & Central nervous systems
DIRECTIONS:
1-5 spray(s); 1-3 time(s) per day or as recommended by your health care practitioner.
Mfg. for
Viatrexx Bio Incorporated.
www.viatrexx.com
Newark, DE 19713

| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 0b4ec9ca-d305-43fc-88dd-7a510313efe0 | Product name | 1 | 20260105 |
| 2ab36713-99a4-1d04-c42f-907afc73b6f9 | Product name | 7 | 20260105 |
| bb209f42-a85f-4fee-9d3d-c9dded168625 | Product name | 1 | 20251208 |
| 49628fc7-2031-4c28-bd31-0ef3aa8f44a3 | Product name | 3 | 20251118 |
| cbf85893-59ef-423f-87d4-a573c000a8b9 | Product name | 8 | 20250731 |
| b5b1095b-40cd-8a9e-b111-502545045b07 | Product name | 4 | 20250325 |
| e190029e-423b-473c-8e04-2ada59b5b711 | Product name | 1 | 20250314 |
| e0031c74-3853-42bc-8e10-86dbbe83992e | Product name | 2 | 20231116 |
| 209a4db0-2639-413d-9ad3-274ad7be11f7 | Product name | 1 | 20230912 |
| 08ddeef6-6d79-428b-a00b-432b50fc2b32 | Product name | 1 | 20230831 |
| f7046b89-2016-499a-adc6-78479172abc6 | Product name | 1 | 20230425 |
| 2686d634-e712-4007-8dbf-3d37c6c4d71f | Product name | 1 | 20181121 |
| fa8b5901-e681-426f-82fe-54f6d81ec698 | Product name | 4 | 20180619 |
| bd49bb86-2d32-4a7a-a594-eeda2e29af42 | Product name | 1 | 20180118 |
| c08ab52f-2fc8-4409-9d9f-ed8edc0bd070 | Product name | 1 | 20171221 |
| 3becbe78-12d9-4ad2-9b4c-1e36f8d1303a | Product name | 1 | 20170815 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 63776-033-15 | 2024-01-30 | C162847 | 48780-1 | 1030e365-3e3e-111a-e063-dadaa90a10e2 | ANS/CNS |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63776-033-15 | ANS/CNS | 30 mL in 1 BOTTLE, SPRAY | SPRAY | 30 | 6 | |
| 63776-033-15 | ANS/CNS | 1 in 1 BOX | SPRAY | 1 | 6 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 63776-033 | ANS/CNS (CHOLINE CHLORIDE, EPINEPHRINE, .GAMMA.-AMINOBUTYRIC ACID, HISTAMINE, GOLDENSEAL, NOREPINEPHRINE, TARAXACUM PALUSTRE ROOT, TYRAMINE) SPRAY [VIATREXX BIO INCORPORATED] | 6 | Legacy NDC, 2 package rows | 20221201_3af34476-26df-8ecd-2198-40b6ee5708b0.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| .gamma.-aminobutyric Acid | ACTIVE INGREDIENT | 2ACZ6IPC6I | 1 | |
| Acetylcholine Chloride | ACTIVE INGREDIENT | AF73293C2R | 1 | |
| Epinephrine | ACTIVE INGREDIENT | YKH834O4BH | 1 | |
| Goldenseal | ACTIVE INGREDIENT | ZW3Z11D0JV | 1 | |
| Histamine | ACTIVE INGREDIENT | 820484N8I3 | 1 | |
| Norepinephrine | ACTIVE INGREDIENT | X4W3ENH1CV | 1 | |
| Taraxacum Palustre Root | ACTIVE INGREDIENT | GCZ4W7077C | 1 | |
| Tyramine | ACTIVE INGREDIENT | X8ZC7V0OX3 | 1 | |
| .gamma.-aminobutyric Acid | ACTIVE MOIETY | 2ACZ6IPC6I | 1 | |
| Acetylcholine | ACTIVE MOIETY | N9YNS0M02X | 1 | |
| Epinephrine | ACTIVE MOIETY | YKH834O4BH | 1 | |
| Goldenseal | ACTIVE MOIETY | ZW3Z11D0JV | 1 | |
| Histamine | ACTIVE MOIETY | 820484N8I3 | 1 | |
| Norepinephrine | ACTIVE MOIETY | X4W3ENH1CV | 1 | |
| Taraxacum Palustre Root | ACTIVE MOIETY | GCZ4W7077C | 1 | |
| Tyramine | ACTIVE MOIETY | X8ZC7V0OX3 | 1 | |
| Alcohol | INACTIVE INGREDIENT | 3K9958V90M | 1 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 63776-033 | 63776-033-15 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| ALCOHOL | 3K9958V90M | IACT |
| WATER | 059QF0KO0R | IACT |
| CHOLINE CHLORIDE | 45I14D8O27 | ACTIB |
| EPINEPHRINE | YKH834O4BH | ACTIB |
| .GAMMA.-AMINOBUTYRIC ACID | 2ACZ6IPC6I | ACTIB |
| HISTAMINE | 820484N8I3 | ACTIB |
| GOLDENSEAL | ZW3Z11D0JV | ACTIB |
| NOREPINEPHRINE | X4W3ENH1CV | ACTIB |
| TARAXACUM PALUSTRE ROOT | GCZ4W7077C | ACTIB |
| TYRAMINE | X8ZC7V0OX3 | ACTIB |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Alcohol | ALCOHOL | 3K9958V90M | SYRUP / ORAL | 21000 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | LIQUID / RESPIRATORY (INHALATION) | 5 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | SUSPENSION / RECTAL | 0.35 %v/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | GEL, METERED / TRANSDERMAL | 3675 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL / NASAL | 20 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / INTRAVENOUS | 6405 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | DROPS / ORAL | 210 mg/1ml | ||
| Alcohol | ALCOHOL | 3K9958V90M | SPRAY / SUBLINGUAL | 397 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | ELIXIR / ORAL | 13675 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | CAPSULE / ORAL | 882 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / INTRAVENOUS | 99 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | TABLET, DELAYED RELEASE / ORAL | NA | ||
| Alcohol | ALCOHOL | 3K9958V90M | SPRAY / TOPICAL | 3633 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | GEL / TRANSDERMAL | 7360 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | LIQUID / INTRAVENOUS | 400 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | DROPS / NASAL | 10 mg/1ml | ||
| Alcohol | ALCOHOL | 3K9958V90M | PASTE / DENTAL | 1.8 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | SPRAY / TRANSDERMAL | 90 %w/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | LOTION / TOPICAL | 25 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / DENTAL | 12.8 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | SWAB / TOPICAL | 2250 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SHAMPOO / TOPICAL | 714 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL, METERED / NASAL | 70 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL, SPRAY / TOPICAL | 561 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SPRAY, METERED / SUBLINGUAL | 29 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | CAPSULE, EXTENDED RELEASE / ORAL | 8 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION / INTRAVENOUS | 92 %w/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | CONCENTRATE / ORAL | 198 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / NASAL | 10 mg/1ml | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION, CONCENTRATE / ORAL | 150.68 mg/1ml | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / OPHTHALMIC | 0.5 %w/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | CONCENTRATE / BUCCAL | 679 mg/1ml | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION / INTRAMUSCULAR | 1491 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION / SUBCUTANEOUS | 149 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION, EMULSION / INTRAVENOUS | 520 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION, CONCENTRATE / INTRAVENOUS | 4000 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SUSPENSION / ORAL | 681 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL / TOPICAL | 561 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / RESPIRATORY (INHALATION) | 0.08 %w/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | POWDER, FOR SOLUTION / TOPICAL | 40 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | JELLY / VAGINAL | NA | ||
| Alcohol | ALCOHOL | 3K9958V90M | SPRAY / NASAL | 20 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / TOPICAL | 2445 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL, METERED / RESPIRATORY (INHALATION) | 26664 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION / INTRAVASCULAR | 100 %v/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL, SPRAY / RESPIRATORY (INHALATION) | 35.75 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | LIQUID / INTRAMUSCULAR | 400 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | LIQUID / ORAL | 3563 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / SUBCUTANEOUS | 6.1 %v/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL, FOAM / TOPICAL | 4504 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / INTRAVESICAL | 7892 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | GEL, METERED / TOPICAL | 541 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | GEL / RECTAL | 898 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / INTRAMUSCULAR | 1000 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / ORAL | 6624 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | GEL / TOPICAL | 9971 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / TRANSDERMAL | 49.37 %w/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | MOUTHWASH / BUCCAL | 200 mg/1ml | ||
| Alcohol | ALCOHOL | 3K9958V90M | GEL / DENTAL | 1.8 %w/w |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| eeb4b80d-909c-ad9e-e053-2a95a90ac607 | 3af34476-26df-8ecd-2198-40b6ee5708b0 | 2022-11-30 | Warnings | eeb4b80d-909c-ad9e-e053-2a95a90ac607 3af34476-26df-8ecd-2198-40b6ee5708b0 |
Adverse event summaries are temporarily unavailable. Other product information remains available.